Search research articles
Contact Us
Filters
Showing results (721-730 of 870) with videos related to
Page
of 87
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2018
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
James J Dignam, Daniel A Hamstra, Herbert Lepor, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2006
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer
Twyla R Willoughby, Patrick A Kupelian, Jean Pouliot, et al.
The Prostate
|
October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH
Zachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy
Richard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Advances in Radiation Oncology
|
August 12, 2017
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy
William C Jackson, Felix Y Feng, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 29, 2020
A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)
Stephen J Freedland, Jenifer Allen, Aubrey Jarman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2021
Correction: A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)
Stephen J Freedland, Jenifer Allen, Aubrey Jarman, et al.
The Prostate
|
September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database
Zachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02
A Pollack, M DeSilvio, L-Y Khor, et al.
Page
of 87
Search research articles
Search
Showing results (721-730 of 870) with videos related to
Sort By:
Page
of 87
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2018
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
James J Dignam, Daniel A Hamstra, Herbert Lepor, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2006
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer
Twyla R Willoughby, Patrick A Kupelian, Jean Pouliot, et al.
The Prostate
|
October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH
Zachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy
Richard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Advances in Radiation Oncology
|
August 12, 2017
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy
William C Jackson, Felix Y Feng, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 29, 2020
A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)
Stephen J Freedland, Jenifer Allen, Aubrey Jarman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2021
Correction: A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)
Stephen J Freedland, Jenifer Allen, Aubrey Jarman, et al.
The Prostate
|
September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database
Zachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02
A Pollack, M DeSilvio, L-Y Khor, et al.
Page
of 87